Terril Brothers’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-158,188
| Closed | -$8.95M | – | 63 |
|
|
2024
Q4 | $8.95M | Buy |
158,188
+7,805
| +5% | +$436K | 2.56% | 12 |
|
|
2024
Q3 | $7.78M | Sell |
150,383
-880
| -0.6% | -$41.3K | 2.58% | 13 |
|
|
2024
Q2 | $6.28M | Sell |
151,263
-94,545
| -38% | -$4.23M | 2.25% | 12 |
|
|
2024
Q1 | $13.3M | Sell |
245,808
-1,305
| -0.5% | -$66.5K | 4.59% | 9 |
|
|
2023
Q4 | $12.7M | Sell |
247,113
-1,806
| -0.7% | -$94.8K | 4.49% | 8 |
|
|
2023
Q3 | $14.4M | Sell |
248,919
-6,098
| -2% | -$374K | 7% | 2 |
|
|
2023
Q2 | $16.3M | Sell |
255,017
-1,470
| -0.6% | -$98.6K | 7.2% | 3 |
|
|
2023
Q1 | $17.8M | Sell |
256,487
-7,443
| -3% | -$525K | 8.35% | 3 |
|
|
2022
Q4 | $19M | Sell |
263,930
-5,275
| -2% | -$398K | 9.3% | 2 |
|
|
2022
Q3 | $19.1M | Sell |
269,205
-1,879
| -0.7% | -$136K | 5.79% | 4 |
|
|
2022
Q2 | $20.9M | Sell |
271,084
-108,390
| -29% | -$8.26M | 7.02% | 3 |
|
|
2022
Q1 | $27.7M | Sell |
379,474
-9,600
| -2% | -$645K | 5.66% | 6 |
|
|
2021
Q4 | $24.3M | Sell |
389,074
-6,793
| -2% | -$398K | 5.33% | 6 |
|
|
2021
Q3 | $23.4M | Sell |
395,867
-10,270
| -3% | -$676K | 5.79% | 3 |
|
|
2021
Q2 | $27.1M | Sell |
406,137
-8,315
| -2% | -$542K | 6.36% | 3 |
|
|
2021
Q1 | $26.2M | Sell |
414,452
-14,010
| -3% | -$872K | 6.66% | 3 |
|
|
2020
Q4 | $26.6M | Sell |
428,462
-12,830
| -3% | -$789K | 7.04% | 2 |
|
|
2020
Q3 | $26.6M | Sell |
441,292
-10,025
| -2% | -$603K | 8.17% | 2 |
|
|
2020
Q2 | $26.5M | Buy |
451,317
+16,108
| +4% | +$963K | 8.74% | 2 |
|
|
2020
Q1 | $24.3M | Sell |
435,209
-9,855
| -2% | -$602K | 10.53% | 1 |
|
|
2019
Q4 | $28.6M | Sell |
445,064
-12,892
| -3% | -$738K | 10.07% | 1 |
|
|
2019
Q3 | $23.2M | Sell |
457,956
-6,398
| -1% | -$301K | 7.84% | 3 |
|
|
2019
Q2 | $21.1M | Sell |
464,354
-6,245
| -1% | -$291K | 6.72% | 4 |
|
|
2019
Q1 | $22.5M | Sell |
470,599
-21,890
| -4% | -$1.09M | 7.08% | 3 |
|
|
2018
Q4 | $25.6M | Sell |
492,489
-1,935
| -0.4% | -$104K | 9.18% | 1 |
|
|
2018
Q3 | $30.7M | Sell |
494,424
-7,980
| -2% | -$474K | 9.46% | 1 |
|
|
2018
Q2 | $27.8M | Buy |
502,404
+4,945
| +1% | +$267K | 8.55% | 1 |
|
|
2018
Q1 | $31.5M | Sell |
497,459
-8,135
| -2% | -$523K | 9.55% | 1 |
|
|
2017
Q4 | $31M | Sell |
505,594
-2,895
| -0.6% | -$181K | 9.54% | 1 |
|
|
2017
Q3 | $32.4M | Sell |
508,489
-3,145
| -0.6% | -$184K | 10.38% | 1 |
|
|
2017
Q2 | $28.5M | Buy |
511,634
+19,605
| +4% | +$1.07M | 10.14% | 2 |
|
|
2017
Q1 | $26.8M | Buy |
492,029
+186,725
| +61% | +$10.2M | 9.45% | 2 |
|
|
2016
Q4 | $17.8M | Buy |
+305,304
| New | +$16.7M | 6.22% | 8 |
|
Other funds holding BMY
Terril Brothers's BMY Position: Q1 2025 in Review
Terril Brothers sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 158,188 shares — an estimated $8.95M sold.
Terril Brothers first reported a position in BMY in Q4 2016 and held it in 33 quarters. The position peaked at $32.4M in Q3 2017. 2,477 funds tracked by Wall St. Rank hold BMY as of Q1 2025.
- Terril Brothers reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
- Terril Brothers sold 158,188 Bristol-Myers Squibb shares in Q1 2025, an estimated $8.95M.
- Terril Brothers first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 33 quarters.
- Terril Brothers's Bristol-Myers Squibb position peaked at $32.4M in Q3 2017.
- 2,477 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.
Based on Terril Brothers's 13F filing for Q1 2025, filed 13 May 2025.